This Article Full Text Full Text (PDF) All Versions of this Article: 147/5/2088    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fliedner, S. Articles by Lehnert, H. Search for Related Content PubMed PubMed Citation Articles by Fliedner, S. Articles by Lehnert, H.

Brain Uptake of Intranasally Applied Radioiodinated Leptin in Wistar Rats

Department of Endocrinology and Metabolism (S.F., C.S., H.L.), Magdeburg University Medical School, 39120 Magdeburg, Germany; and Warwick Medical School (H.L.), Coventry University Hospital, Coventry CV2 2DX, United Kingdom

Address all correspondence and requests for reprints to: Dr. Carla Schulz, Department of Endocrinology and Metabolism, Otto-von-Guericke University, Leipziger Strasse 44, 39120 Magdeburg, Germany. E-mail: carla.schulz{at}medizin.uni-magdeburg.de.

Leptin is mainly synthesized and secreted by fat cells in proportion to adipose tissue mass. Under physiological conditions, this hormone reduces food intake and increases thermogenesis through interactions with neurons in the central nervous system. However, transport of leptin into the central nervous system via the blood-brain barrier is saturable, and in obesity the feedback signal to the brain is markedly insufficient. In recent experiments we have shown, that intranasal (i.n.) delivery of leptin reduces food intake in rats. The aim of the present study was to explore the distribution of i.n. delivered leptin within brain, blood, and peripheral tissues. Application of [¹²⁵I]leptin (0.03, 0.1, and 0.2 mg/kg) into male Wistar rats’ nares (n = 8 per group) leads to supraphysiological brain leptin concentrations 30 min after application, with contents in the hypothalamus (7.3 ± 2.6, 5.9 ± 1.6, and 13.8 ± 5.7 ng/g; P = 0.023; F = 6.157) being significantly higher than the brain average (1.2 ± 0.2, 3.9 ± 1.0, and 6.0 ± 1.9 ng/g). In contrast, contents in the occipital/entorhinal cortex were lower than the brain average, indicating a minor participation of the transport via cerebrospinal fluid, which would have favored cerebrospinal fluid-exposed surfaces. In experiments employing the application of unlabeled leptin administered iv, we were able to show that excess blood leptin does not diminish brain uptake of i.n. leptin (as indicated by [¹²⁵I]leptin), supporting a direct transport from nose to brain by circumvention of the blood-brain barrier. This study thus clearly demonstrates a rapid and highly effective transport of leptin from nose to brain.

This article has been cited by other articles:

				L. G. Bermudez-Humaran, S. Nouaille, V. Zilberfarb, G. Corthier, A. Gruss, P. Langella, and T. Issad Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice Appl. Envir. Microbiol., August 15, 2007; 73(16): 5300 - 5307. [Abstract] [Full Text] [PDF]

				K. E. Foster-Schubert and D. E. Cummings Emerging Therapeutic Strategies for Obesity Endocr. Rev., December 1, 2006; 27(7): 779 - 793. [Abstract] [Full Text] [PDF]

				A. J. Kastin and W. Pan Intranasal Leptin: Blood-Brain Barrier Bypass (BBBB) for Obesity? Endocrinology, May 1, 2006; 147(5): 2086 - 2087. [Full Text] [PDF]